NOTICE
ANSM - Last updated: 31/07/2017
Name of the medicinal product
VITAMIN C UPSA EFFERVESCENT 1000 mg, effervescent tablet
Ascorbic acid
framed
Please read this leaflet carefully before you start taking this medicine because it contains important information for you.
You should always take this medication exactly as prescribed in this leaflet or by your doctor, pharmacist or nurse.
· Keep this leaflet. You might need to read it again.
· Ask your pharmacist for advice or information.
· If you experience any side effects, talk to your doctor, pharmacist or nurse. This also applies to any side effects not mentioned in this leaflet. See section 4.
· You should contact your doctor if you experience no improvement or feel less well after 1 month.
What is in this leaflet?
1. What is VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet and in which cases it is used?
2. What should I tell you before taking VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet?
3. How to take VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet?
4. What are the possible side effects?
5. How to store VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet?
6. Package contents and other information.
1. WHAT VITAMIN C UPSA EFFERVESCENTE 1000 mg, effervescent tablet AND IN WHAT CASES IS IT USED?
Pharmacotherapeutic group: VITAMIN C, unassociated - ATC code: A11GA01.
This medication contains vitamin C.
It is indicated in the states of transient fatigue of the adult and the child of more than 15 years.
You should contact your doctor if you experience no improvement or feel less well after 1 month.
2. BEFORE YOU TAKE VITAMIN C UPSA EFFERVESCENTE 1000 mg, effervescent tablet?
Do not take VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet:
· if you are allergic to the active substance or to any of the other ingredients of this medication mentioned in section 6.
· if you have a kidney stone for doses greater than 1g / day.
IN CASE OF DOUBT, IT IS ESSENTIAL TO ASK FOR THE OPINION OF YOUR DOCTOR OR YOUR PHARMACIST.
Warnings and Precautions
Talk to your doctor or pharmacist before taking VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet.
This medicine contains vitamin C. Other medicines contain this medication.
Make sure you do not take any other medicines containing vitamin C, including if they are medicines obtained without a prescription.
Do not combine them, so as not to exceed the recommended daily dose.
(see "Posology" and "Symptoms and Instructions for Overdose").
If symptoms persist after 1 month of treatment or aggravation of the disorders, medical advice is necessary.
Due to a slightly stimulating effect, it is advisable not to take vitamin C at the end of the day.
This medicine contains sodium. This medicine contains 283 mg of sodium per tablet. To be taken into account in patients controlling their sodium dietary intake.
This medication contains an azo coloring agent (E110, S orange yellow) and may cause allergic reactions.
The use of this medication is not recommended in patients with fructose intolerance, glucose-galactose malabsorption syndrome or sucrase / isomaltase deficiency (rare hereditary diseases).
Vitamin C should be used with caution in patients with iron metabolism disorders, predisposed to the formation of urinary or renal lithiasis (presence of crystals in the urine or kidneys) and in subjects deficient in glucose-6 phosphate dehydrogenase .
IN CASE OF DOUBT DO NOT HESITATE TO REQUEST THE NOTICE OF YOUR DOCTOR OR PHARMACIST.
Children and Youth
This medication is indicated for adults and children over 15 years of age.
Other medicines and VITAMIN C UPSA EFFERVESCENTE 1000 mg, effervescent tablet
Inform your doctor or pharmacist if you are taking, have recently taken or may take any other medicines.
Tell your doctor or pharmacist if you are taking deferoxamine to remove excess iron and aluminum from the blood.
At doses greater than 2 g / day in vitamin C, ascorbic acid may interfere with the following biological tests: blood and urine creatinine and glucose assays (diabetic control by glucose oxidase test).
VITAMIN C UPSA EFFERVESCENT 1000 mg, effervescent tablet with food, beverages and alcohol
Not applicable.
Pregnancy, breast-feeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or plan a pregnancy, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy and breast feeding
This medication will only be used during pregnancy on the advice of your doctor.
The use of vitamin C should be avoided during breastfeeding
Fertility
Not applicable
Driving and using machines
VITAMIN C UPSA EFFERVESCENTE 1000 mg, effervescent tablet has no effect on the ability to drive and use machines has been observed.
VITAMIN C UPSA EFFERVESCENTE 1000 mg, effervescent tablet contains orange yellow S (E110), sucrose and sodium (283 mg per tablet).
3. HOW TO TAKE VITAMIN C UPSA EFFERVESCENTE 1000 mg, effervescent tablet?
Always take this medication exactly as prescribed in this leaflet or as directed by your doctor, pharmacist or nurse. Check with your doctor, pharmacist or nurse if in doubt.
Dosage
This presentation is reserved for adults and children over 15 years of age.
1 effervescent tablet per day. It is preferable not to exceed 1 g per day, that is 1 tablet per day.
Due to the presence of vitamin C, avoid taking at the end of the day.
Administration mode
Oral use.
Dissolve the tablet in half a glass of water.
Duration of the treatment
Treatment will be limited to 1 month.
If you take more VITAMIN C UPSA EFFERVESCENT 1000 mg, effervescent tablet than you should
In case of overdose or accidental poisoning, notify a doctor immediately.
If you forget to take VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet
Do not take a double dose to make up for a missed dose.
If you stop taking VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet
Not applicable.
4. WHAT ARE POSSIBLE SIDE EFFECTS?
Like all medicines, this medicine may cause side effects, although not everybody gets them.
In doses above 1 g / d in vitamin C, possibility of: digestive disorders (stomach burns, diarrhea, abdominal pain), urinary disorders (discomfort with urine emission or abnormal coloring of the urine).
At doses above 3 g / d in vitamin C, hemolysis (destruction of red blood cells) in glucose 6 deficient phosphate dehydrogenase (lack of an enzyme in red blood cells).
Cases of dizziness, urticaria and rash have been reported.
Declaration of side effects
If you experience any side effects, talk to your doctor, pharmacist or nurse. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and network of Regional Centers of Pharmacovigilance - Website: www.ansm.sante.fr
By reporting adverse reactions, you are helping to provide more information about the safety of the drug.
5. HOW TO STORE VITAMIN C UPSA EFFERVESCENTE 1000 mg, effervescent tablet?
Keep this medicine out of the reach and sight of children.
Do not use this medicine after the expiry date which is stated on the package. The expiry date refers to the last day of that month.
No special storage conditions.
Do not throw any medicines into drains or rubbish. Ask your pharmacist to remove any medications you are no longer using. These measures will help protect the environment.
6. PACKAGE CONTENTS AND OTHER INFORMATION
What VITAMINE C UPSA EFFERVESCENTE 1000 mg contains: effervescent tablet
· The active substance is:
Ascorbic acid................................................ .................................................. ........ 1000 mg
For an effervescent tablet.
· The other components are:
Sodium bicarbonate, anhydrous citric acid, sucrose, sodium saccharin, macrogol 6000, sodium benzoate, orange flavor, orange-yellow S.
What is VITAMINE C UPSA EFFERVESCENTE 1000 mg, effervescent tablet and contents of the pack
This medication is in the form of an effervescent tablet.
Box of 10, 20 or 100 tablets.
Marketing Authorization Holder
UPSA SAS
3, RUE JOSEPH MONIER
92500 RUEIL-MALMAISON
Marketing Authorization Operator
UPSA SAS
3, RUE JOSEPH MONIER
92500 RUEIL-MALMAISON
Maker
UPSA SAS
304, avenue du docteur jeaN bru
47000 agen
or
UPSA SAS
979, AVENUE DES PYRENEES
47520 THE PASSAGE
Names of the medicinal product in the Member States of the European Economic Area
Not applicable.
The last date on which this leaflet was revised is:
[to be completed later by the holder]
{month YYYY}.
Other
Detailed information on this medicine is available on the ANSM website
Health Education Council:
This medication is intended to alleviate a temporary state of fatigue.
It is necessary to distinguish normal physical fatigue occurring as a result of a major effort for example and asthenia which is fatigue outside of any effort.
· Fatigue arising from physical exertion is normal: rest is enough to make it disappear.
· Fatigue that does not give in to rest or asthenia is the feeling of not being able to provide an effort before it even began. This fatigue can be the consequence of overwork, of a disease.
Some medications may also cause unusual fatigue: read the package leaflet for medications you are taking and ask for advice from your pharmacist or doctor. But in many cases no precise cause is found.
Fatigue can be manifested by very variable symptoms. This can be a general impression of weakness. But sometimes symptoms can be associated with it such as sleep disorders (insomnia, restless sleep, ...), intellectuals (difficulties of concentration, memory and attention ...), sexual (decreased desire ...) of the character (irritability, pessimism, sadness, demotivation ...).
You can reduce your fatigue by respecting as much as possible the following tips:
· Rest, relax, look for the reasons for your fatigue.
· Practice regular and appropriate physical activity.
· Have a balanced diet (especially avoid alcohol, tobacco, stimulants).
· Find your sleeping rhythm (regular bedtime and sufficient sleeping time).
Seek advice from your pharmacist or doctor in the following cases:
· No improvement after 1 month of treatment.
· Increased feeling of fatigue during treatment.
· Occurrence of new symptoms or unusual symptoms.